Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
SPRO
#3194
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.46%
Changement Mensuel
-8.05%
Evolution sur 6 mois
+10.15%
Changement Annuel
+178.21%
Clôture Précédente
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
Volume
8
Marchés
Actions des Marchés US
Soins de Santé
SPRO
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
29.5 M
32.76 M
52.57 M
53.87 M
55.9 M
—
Valuation ratios
Enterprise value
486.88 M
411.84 M
-17.63 M
5.55 M
4.69 M
185.36 M
Price to earnings ratio
—
—
-1.41
3.53
-0.81
-6.71
Price to sales ratio
—
—
1.22
0.78
1.16
7.85
Price to cash flow ratio
—
—
-8.46
-2.44
-2.37
6.05
Price to book ratio
—
—
0.86
0.75
1.21
3.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.51
0.52
0.37
0.13
0.62
0.53
Return on equity %
0.59
1.02
0.61
0.21
1.49
1.19
Return on invested capital %
1 225.35
1 563.16
698.97
122.86
412.12
—
Gross margin %
100
100
100
100
100
400
Operating margin %
847.94
481.87
78.86
20.7
152.91
557.88
EBITDA margin %
—
—
—
—
—
—
Net margin %
839.23
491.89
86.74
21.98
142.91
522.53
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.7
8.46
5.25
3.53
2.19
12.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.36
0.68
0.33
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
—
0.21
0.62
0.43
-1.13
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
2.9
1.44
0.98
3.28
Net current asset value per share
—
—
3.02
2.48
1.99
5.32
Tangible book value per share
—
—
2.02
2.02
0.85
2.52
Working capital per share
—
—
2.45
1.77
1.08
3.38
Book value per share
—
—
2.02
2.02
0.85
2.52
Nouvelles
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Keutzer, directeur des opérations de Spero Therapeutics, vend des actions pour 44k€
Keutzer, Spero Therapeutics COO, sells $44k in shares
Le PDG de Spero Therapeutics vend des actions pour 207.484€
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
Le BPA de Spero Therapeutics a dépassé les attentes de 0,26$, le CA en dessous des prévisions
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates
La PDG de Spero Therapeutics, Rajavelu, vend des actions pour 95k€
Spero therapeutics CEO Rajavelu sells $95k in stock